Tradestie Institutional Equity Comparison Engine

KTTA vs ISPC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KTTA Overall Edge

KTTA Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus ISPC at N/M Forward P/E and -1455.3% operating margin (+128.9% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ISPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
KTTA N/M vs ISPC N/M Fwd P/E
Growth & Margin Winner KTTA
Op Margin 0.0% vs -1455.3% ยท YoY +1498.1% vs +128.9%
Momentum & Technical Winner KTTA
1Y +0.6% vs -10.0% ยท 52W Pos 11% vs 5%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap $17.7M
1M Return +7.52%
1Y Return +0.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 50.0 Mom 60.0
ISPC NASDAQ
iSpecimen Inc. Common Stock
Services-Commercial Physical & Biological Research
$0.46
-13.58% 1D
Market Cap $3.1M
1M Return -45.2%
1Y Return -10.0%
Forward P/E N/M
Unified AI Score
41.6 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KTTA +0.59% ISPC -10.0% Spread: +10.59 pp (KTTA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period KTTA Revenue ISPC Revenue KTTA Op. Margin ISPC Op. Margin Margin Edge
FY2020 N/A $10M N/A -29.4% ISPC
FY2021 $0M $10M -29925.7% -53.2% ISPC
FY2022 $0M $10M -2587.3% -97.9% ISPC
FY2023 N/A $10M N/A -112.5% ISPC
FY2024 N/A $10M N/A -137.0% ISPC
FY2025 N/A $0M N/A -465.4% ISPC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KTTA (6) vs ISPC (1)
Institutional Metric KTTA ISPC Criterion Row Winner
Market Capitalization Scale $17.7M $3.1M Larger Scale KTTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +1498.1% +128.9% Higher Growth KTTA
Operating Margin (TTM) Profitability 0.0% -1455.3% Higher Margin KTTA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -88.8% -303.9% Higher ROE KTTA
52-Week Range Position Momentum 11% ($0โ€“$2) 5% ($0โ€“$7) Stronger Trend KTTA
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 185% Vol -10.07ฮฒ ยท 74% Vol Lower Realized Risk ISPC
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 41.6 / 100 (SELL) Higher Composite KTTA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KTTA vs ISPC Buy Guide
KTTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ISPC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ISPC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KTTA nor ISPC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.